Skip to main content

Unable to load price data. Sorry.


NPS Pharmaceuticals, Inc. (NASDAQ:NPSP.DL)

CAPS Rating: No stars

A biopharmaceutical company focused on the development and commercialization of small molecule drugs and recombinant proteins.

Unable to load market data for this Ticker. Sorry.



This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform

All-Star Players

0 Outperform
0 Underperform

Wall Street

0 Outperform
0 Underperform

Top NASDAQ:NPSP.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

muksdotca (< 20)
Submitted March 21, 2008

When everyone was watching BSC and the sky falling NSPS reported positive top-line results from a 28-week blinded Phase 3-extension study of GATTEX(TM) to deaf ears.NPS Reports Successful GATTEX(TM) Extension… More

synergize (27.98)
Submitted June 09, 2008

NPS Pharmaceuticals, Inc. (NPS) is a biopharmaceutical company engaged in the development of specialty therapeutics to treat gastrointestinal (GI) and endocrine disorders with unmet medical need. As of April 15, 2008, the Company was advancing two… More


  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about NPSP.DL.

No one has written a Pitch for NPSP.DL stock yet. Tell us why you think NPSP.DL will outperform or underperform against the market.


Find the members with the highest scoring picks in NPSP.DL.

No players have picked NPSP.DL yet. Tell us why you think NPSP.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for NPSP.DL.